Kindred Healthcare Inc (KND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published : Nov-2017

No. of Pages : 96

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Kindred Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Kindred Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 11
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Gentiva Health Completes Acquisition Of Healthcare Businesses From Harden Healthcare For US$409 Million 14
Kindred Healthcare To Acquire Western Reserve Senior Care 16
Kindred To Acquire Assets Of Arrowhead Home Health And Arrowhead Hospice Centers 17
Kindred To Acquire Assets Of All Heart Home Health Agency and Hospice 18
Kindred Healthcare To Acquire Qstaff Home Healthcare And Advanced Care Hospice 19
Kindred Healthcare To Acquire Operations Of Mercy Continuing Care Hospital 20
Gentiva Health Services Acquires Advocate Hospice, Healthcare Provider 21
Kindred Healthcare Acquires Home Healthcare Assets Of Synergy Home Health 22
IntegraCare Acquires Medicare Services Business From Outreach Health Services 23
Kindred Healthcare Acquires Four California Home Health Agencies From CareSouth HHA 24
Partnerships 25
Kindred Healthcare to Form Joint Venture with Dignity Health 25
Gentiva Health Services Forms Joint Venture With Wake Forest University Baptist Medical Center 26
Kindred Healthcare Forms Joint Venture with Dignity Health 27
Equity Offering 28
Kindred Healthcare to Raise Funds through Public Offering of Shares 28
Kindred Healthcare to Raise USD150 Million in Public Offering of Units 30
Kindred Healthcare Raises USD213.8 Million in Public Offering of Shares 32
Gentiva Health Services Files Registration Statement For Public Offering Of Securities For Up To US$300 Million 34
Debt Offering 35
Kindred Healthcare Prices Private Placement Of Notes Due 2022 For US$500 Million 35
Kindred Healthcare Completes Private Placement Of Senior Notes Due 2019 For US$550 Million 36
Asset Transactions 37
Vibra Healthcare Completes Acquisition Of Remaining Two Hospitals From Kindred For US$20.7 Million 37
Signature Healthcare Completes Acquisition Of Seven Nursing Centers From Kindred Healthcare 39
Signature Healthcare Acquires Six Skilled Nursing Centers From Kindred Healthcare 40
Extended Care Hospital Acquires Long Term Acute Care Facility From Kindred Healthcare 41
Southern Home Care Services Acquires Rehab Without Walls Business For US$9.8 Million 42
Acquisition 43
Kindred Healthcare Acquires Centerre Healthcare for USD195 Million 43
Kindred Healthcare to Acquire Gentiva Health Services for USD1.8 Billion 44
Kindred Healthcare Completes Acquisition Of Senior Home Care, Provider Of Home Health For US$95 Million 46
Kindred Healthcare To Acquire Synergy Home Care 47
Kindred Healthcare Acquires TherEX, Rehabilitation Company, For US$14 Million 48
Kindred Healthcare To Acquire Caring Hearts Home Health 49
Kindred Healthcare Acquires Homecare Advantage For US$2 Million 50
Gentiva Health Services Acquires North Mississippi Hospice, Provider Of Palliative Care 51
Gentiva Health Services Acquires Family Home Care, Provider Of Home Health And Hospice Services 52
Kindred Healthcare Completes Acquisition Of IntegraCare For US$71 Million 53
Gentiva Health Services Sells Remaining 31% Stake In CareCentrix 54
Kindred Healthcare Acquires Professional HealthCare For US$51 Million 55
Kindred Healthcare Completes Acquisition Of RehabCare 56
Gentiva Health Services Acquires Remaining Minority Stake In Odyssey Healthcare of Augusta 58
Kindred Healthcare Inc - Key Competitors 59
Kindred Healthcare Inc - Key Employees 60
Kindred Healthcare Inc - Locations And Subsidiaries 61
Head Office 61
Other Locations & Subsidiaries 61
Joint Venture 62
Recent Developments 63
Strategy And Business Planning 63
Jun 28, 2017: Kindred Healthcare, Billings Clinic and St. Vincent Healthcare Announce Plans for Rehabilitation Hospital 63
Jul 28, 2016: Kindred Healthcare and CHI Franciscan Health Announce Plans for Inpatient Rehabilitation Hospital 64
Financial Announcements 65
Nov 06, 2017: Kindred Healthcare Reports Third Quarter 2017 Results 65
Aug 03, 2017: Kindred Healthcare Reports Second Quarter 2017 Results 68
May 03, 2017: Kindred Healthcare Reports First Quarter 2017 Results 70
Feb 27, 2017: Kindred Healthcare Reports Fourth Quarter 2016 Results 73
Nov 07, 2016: Kindred Healthcare Updates Strategy and Reports Third Quarter 2016 Results 74
Aug 04, 2016: Kindred Healthcare Reports Second Quarter 2016 Results at High End of Guidance Range 77
May 04, 2016: Kindred Healthcare Reports First Quarter 2016 Results 80
Mar 31, 2016: Kindred Outlines Solutions for Aging Americans with Quality, Innovation and Social Responsibility Report 82
Feb 25, 2016: Kindred Healthcare Reports Fourth Quarter 2015 Results 85
Corporate Communications 87
May 30, 2017: Kindred Appoints Brian Holzer, M.D., as President of Kindred Innovations and William Altman as Chief of Staff to Chief Executive Officer 87
Nov 02, 2016: Kindred Announces Appointment of Dr. Lynn Simon to Board of Directors 88
Aug 15, 2016: Kindred Appoints Jason Zachariah as President of Kindred Rehabilitation Services 89
Legal and Regulatory 90
Jan 12, 2016: Kindred Announces Settlement with the United States Department of Justice over RehabCare Investigation 90
Other Significant Developments 91
Sep 20, 2017: Kindred Provides Estimated Impact of Hurricanes Irma and Harvey 91
Aug 01, 2017: Kindred Healthcare to Convert Existing Long-Term Acute Care Hospital into Inpatient Rehabilitation Hospital in Partnership with Community Health Network 92
Sep 01, 2016: Silver State ACO: Medicare Shared Savings Program Performance Year 2015 Quality and Financial Results 93
Jun 28, 2016: Select Medical Holdings Announces Completion of Exchange of Hospitals with Kindred Healthcare 94
Jun 01, 2016: Select Medical Holdings Announces Partial Completion of Exchange of Hospitals with Kindred Healthcare 95
Appendix 96
Methodology 96
About GlobalData 96
Contact Us 96
Disclaimer 96

List of Tables
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Kindred Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Kindred Healthcare Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Kindred Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 11
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Gentiva Health Completes Acquisition Of Healthcare Businesses From Harden Healthcare For US$409 Million 14
Kindred Healthcare To Acquire Western Reserve Senior Care 16
Kindred To Acquire Assets Of Arrowhead Home Health And Arrowhead Hospice Centers 17
Kindred To Acquire Assets Of All Heart Home Health Agency and Hospice 18
Kindred Healthcare To Acquire Qstaff Home Healthcare And Advanced Care Hospice 19
Kindred Healthcare To Acquire Operations Of Mercy Continuing Care Hospital 20
Gentiva Health Services Acquires Advocate Hospice, Healthcare Provider 21
Kindred Healthcare Acquires Home Healthcare Assets Of Synergy Home Health 22
IntegraCare Acquires Medicare Services Business From Outreach Health Services 23
Kindred Healthcare Acquires Four California Home Health Agencies From CareSouth HHA 24
Kindred Healthcare to Form Joint Venture with Dignity Health 25
Gentiva Health Services Forms Joint Venture With Wake Forest University Baptist Medical Center 26
Kindred Healthcare Forms Joint Venture with Dignity Health 27
Kindred Healthcare to Raise Funds through Public Offering of Shares 28
Kindred Healthcare to Raise USD150 Million in Public Offering of Units 30
Kindred Healthcare Raises USD213.8 Million in Public Offering of Shares 32
Gentiva Health Services Files Registration Statement For Public Offering Of Securities For Up To US$300 Million 34
Kindred Healthcare Prices Private Placement Of Notes Due 2022 For US$500 Million 35
Kindred Healthcare Completes Private Placement Of Senior Notes Due 2019 For US$550 Million 36
Vibra Healthcare Completes Acquisition Of Remaining Two Hospitals From Kindred For US$20.7 Million 37
Signature Healthcare Completes Acquisition Of Seven Nursing Centers From Kindred Healthcare 39
Signature Healthcare Acquires Six Skilled Nursing Centers From Kindred Healthcare 40
Extended Care Hospital Acquires Long Term Acute Care Facility From Kindred Healthcare 41
Southern Home Care Services Acquires Rehab Without Walls Business For US$9.8 Million 42
Kindred Healthcare Acquires Centerre Healthcare for USD195 Million 43
Kindred Healthcare to Acquire Gentiva Health Services for USD1.8 Billion 44
Kindred Healthcare Completes Acquisition Of Senior Home Care, Provider Of Home Health For US$95 Million 46
Kindred Healthcare To Acquire Synergy Home Care 47
Kindred Healthcare Acquires TherEX, Rehabilitation Company, For US$14 Million 48
Kindred Healthcare To Acquire Caring Hearts Home Health 49
Kindred Healthcare Acquires Homecare Advantage For US$2 Million 50
Gentiva Health Services Acquires North Mississippi Hospice, Provider Of Palliative Care 51
Gentiva Health Services Acquires Family Home Care, Provider Of Home Health And Hospice Services 52
Kindred Healthcare Completes Acquisition Of IntegraCare For US$71 Million 53
Gentiva Health Services Sells Remaining 31% Stake In CareCentrix 54
Kindred Healthcare Acquires Professional HealthCare For US$51 Million 55
Kindred Healthcare Completes Acquisition Of RehabCare 56
Gentiva Health Services Acquires Remaining Minority Stake In Odyssey Healthcare of Augusta 58
Kindred Healthcare Inc, Key Competitors 59
Kindred Healthcare Inc, Key Employees 60
Kindred Healthcare Inc, Subsidiaries 61
Kindred Healthcare Inc, Joint Venture 62

List of Figures
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Kindred Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Kindred Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 11

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Kindred Healthcare Inc (KND) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027